abstract |
The invention relates to lipid compounds of formula (I) and their pharmaceutically acceptable salts for the prevention and/or treatment of ophthalmic disorders such as retinal degenerative disorders and ocular inflammatory diseases: (I) (wherein R 1 is either a C 9 to C 22 alkyl group, or a C 9 to C 22 alkenyl group having from 1 to 6 double bonds; R 2 is selected from the group consisting of a halogen atom, a hydroxy group, an alkyl group, an alkoxy group, an alkylthio group, a carboxy group, an acyl group, an amino group, and an alkylamino group; R 3 is a hydrogen atom, or a group R 2 ; R 4 is a carboxylic acid or a derivative thereof; and X is methylene (-CH 2 -), or an oxygen or sulfur atom). |